Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group;Tos ferina en España. Situación epidemiológica y estrategias de prevención y control. Recomendaciones del Grupo de Trabajo de Tos ferina

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 31, Issue 4, 2013, Pages 240-253

  Campins, Magda ^a   Moreno Pérez, David ^b   Gil De Miguel, Angel ^a   González Romo, Fernando ^a   Moraga Llop, Fernando A ^c   Arístegui Fernández, Javier ^b   Goncé Mellgren, Anna ^a   Bayas, José M ^c   Salleras Sanmartí, Lluís ^a  

^a Salud Pública e Higiene ^*  (Spain)

^b Hospital Clínico   (Spain)

^c Asociación Española de Vacunología   (Spain)

Author keywords

Epidemiology; Pertussis; Vaccination

Indexed keywords

PERTUSSIS VACCINE;

DISEASE CONTROL; GESTATIONAL AGE; GROUPS BY AGE; HUMAN; INCIDENCE; MASS IMMUNIZATION; PERTUSSIS; PREGNANT WOMAN; REVIEW; SPAIN;

ADOLESCENT; ADULT; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS VACCINE; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HEALTH PERSONNEL; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; PERTUSSIS VACCINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SPAIN; VACCINATION; WHOOPING COUGH;

EID: 84876028113     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2012.12.011     Document Type: Review

References (130)

1. F. Zepp, U. Heininger, J. Mertsola, E. Bernatowska, N. Guiso, and J. Roord Rationale for pertussis booster vaccination throughout life in Europe Lancet Infect Dis 11 2011 557 570
2. EUVAC-NET pertussis surveillance final report 1998-2002. 2003. [consultado 26 ene 2013]. Disponible en: http://www.euvac.net/graphics/euvac/ pdf/pertussis1.pdf
3. European Centre for Disease Prevention and Control. EUVAC.NET. Pertussis surveillance report 2010. [consultado 26 ene 2013]. Disponible en: http://www.euvac.net/graphics/euvac/pdf/pertussis-2010.pdf
4. M.J. Devine, M.A. Bellis, K. Tocque, and Q. Syed Whooping cough surveillance in the north west of England Commun Dis Public Health 1 1998 121 125
5. M.L. Ciofi degli Atti, S. Salmaso, A. Bella, R. Arigliani, M. Gangemi, and G. Chiamenti Pediatric sentinel surveillance of vaccine-preventable diseases in Italy Pediatr Infect Dis J 21 2002 763 768
6. M. Wiese-Posselt, and W. Hellenbrand Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation Eurosurveillance 15 2010 19548
7. S.C. De Greeff, F.R. Mooi, J.F. Schellekens, and H.E. de Melker Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands Pediatr Infect Dis J 27 2008 218 223
8. Health Protection Agency. Guidelines for the public health management of pertussis. Updated October, 2012. [consultado 26 ene 2013]. Disponible en: www.hpa.org.uk
9. U. Heininger, and J.D. Cherry Pertussis immunisation in adolescents and adults - Bordetella pertussis epidemiology should guide vaccination recommendations Expert Opin Biol Ther 6 2006 685 697
10. Ministerio de Sanidad, Política Social e Igualdad. Coberturas de vacunación. Datos estadísticos. [consultado 26 ene 2013]. Disponible en: http://www.msc.es/profesionales/saludPublica/prevPromocion/ vacunaciones/coberturas.htm
11. Situación de la tos ferina en España. Red Nacional de Vigilancia Epidemiológica de España. Año 2009. Centro Nacional de Epidemiología. Instituto de Salud Carlos III. [consultado 18 dic 2011]. Disponible en: http://www.isciii.es/htdocs/centros/epidemiologia/pdf/ Informetosferinajunio2009.pdf
12. Centro Nacional de Epidemiología Estado de las enfermedades de declaración obligatoria BES 19 2011 247 260
13. García M, Campins M, Roca J, Moraga F, Baquero F, Gené A, et al. Bordetella pertussis infection in infants and their household contacts. 4 th Congress of the World Society for Pediatric Infectious Diseases (WSPID). Varsovia (Polonia), 1-4 de septiembre de 2005 (abstract book, p. 49).
14. F. Kowalzik, A.P. Barbosa, V.R. Fernández, P.R. Carvalho, M.L. Avila-Agüero, and D.Y.T. Goh Prospective multinational study of pertussis infection in hospitalized infants and their household contacts Pediatr Infect Dis J 26 2007 238 242
15. S. Iglesias, X. Martínez, G. Codina, P. Gorriz, M. Campins, and F.A. Moraga-Llop Importancia de la tos ferina en el lactante. Justificación de una nueva estrategia para su prevención J.R. De Juanes, XVII Jornadas Internacionales sobre Actualización en Vacunas, 2009 2009 ASFORISP Madrid 53 60
16. S. Uriona, X. Martínez, M. Campins, G. Codina, A. Ferrer, and J.A. Rodrigo Estudio de contactos de casos pediátricos de tos ferina en un hospital de tercer nivel de Barcelona Med Clin (Barc) 2012 10.1016/j.medcli. 2012.09.017
17. L. Salleras Vacunaciones del adolescente 2003 Masson Barcelona 931 946
18. a ed 2007 Acindes Madrid 1411 1436
19. F. Moraga, J. Roca, C. Méndez, C. Rodrigo, V. Pineda, and A. Martínez Epidemiology and surveillance of pertussis among infants in Catalonia, Spain, during 1997-2001 Pediatr Infect Dis J 24 2005 510 513
20. Servei de Vigilància Epidemiològica de la Direcció de Salut Pública Resultats del programa pilot de vigilància de la tos ferina a Cataluya Butlletí Epidemiològic de Catalunya 26 2005 1 8
21. Romero M, Domínguez A, Cardeñosa N, Carmona G, Codina G, Fuentes M, and the Catalonia Pertussis Working Group. Detection of cases of pertussis by a surveillance programme: revaccination concerns. Fifth World Congress on Vaccines, Immunization and Immunotherapy (WCVII 2006 CANADA). Montreal, 6-9 november 2006; poster P-1.1.
22. Ministerio de Sanidad y Consumo Clasificación internacional de enfermedades, 9.revisión modificación clínica 1994 MSC Madrid
23. A.E. Tozzi, E. Pandolfi, L.P. Celentano, M. Massari, S. Salmaso, and M.L. Ciofi degli Atti Comparison of pertussis surveillance systems in Europe Vaccine 25 2007 291 297
24. R. Gil Prieto, F.A. Moraga-Llop, J.M. Santos, A. Álvaro, and A. Gil Epidemiología de las hospitalizaciones atribuibles a tos ferina en niños menores de 12 meses en España (1999-2005) Vacunas 10 2009 32 36
25. A. Gil, I. Oyaguez, P. Carrasco, and A. González Hospital admissions for pertussis in Spain, 1995-1998 Vaccine 19 2001 4791 4794
26. J.M. Santos, R. Gil, A. Álvaro, and A. Gil Epidemiología de las hospitalizaciones atribuibles a infección por Bordetella pertussis en población general en España, 1999-2005 Vacunas 9 2008 50 56
27. a ed 2011 Elsevier Madrid
28. R.M. Ghanaie, A. Karimi, H. Sadeghi, A. Esteghamti, F. Falah, and S. Armin Sensivitiy and specificity of the World Health Organization pertussis clinical case definition Int J Infect Dis 14 2010 e1072 e1075
29. World Health Organization. Recommended standards for surveillance of selected vaccine-preventable diseases. Immunization surveillance, assessment and monitoring. WHO; 2003. [consultado 26 ene 2013]. Disponible en: http://www.who.int/immunization-monitoring/diseases/pertussis-surveillance/en/ index.html
30. Faulkner A, Skoff T, Martin S, Cassiday P, Tondella ML, Liang J, et al. Pertusis. En: Roush SW, McIntyre L, Baldy LM, editores. Centers for Disease Control and Prevention. Manual for the surveillance of vaccine-preventable diseases. 5 th ed. 2012. [consultado 26 ene 2013]. Disponible en: http://www.cdc.gov/vaccines/pubs/surv-manual/index.html
31. J.D. Cherry, T. Tan, C.H. Wirsing von König, K.D. Forsyth, U. Thisyakorn, and D. Greenberg Clinical definitions of pertussis: summary of a global pertussis initiative roundtable meeting, February 2011 Clin Infect Dis 54 2012 1756 1764
32. I. Levene, and I. Wacogne Question 3. Is measurement of the lymphocyte count useful in the investigation of suspected pertussis in infants? Arch Dis Child 96 2011 1203 1205
33. A.E. Tozzi, L.P. Celentano, M.L. Ciofi degli Atti, and S. Salmaso Diagnosis and management of pertussis CMAJ 172 2005 509 515
34. A. Zouari, H. Smaoui, and A. Kechrid The diagnosis of pertussis: which method to choose Crit Rev Microbiol 38 2012 111 121
35. Grupo de expertos en vacunación contra la tos ferina Consenso para el diagnóstico clínico y microbiológico y la prevención de la infección por Bordetella pertussis Salud Publica Mex 53 2011 57 65
36. N. Guiso, C.H. Wirsing von König, K. Forsyth, T. Tan, and S.A. Plotkin The Global Pertussis Initiative: report from a round table meeting to discuss the epidemiology and detection of pertussis. Paris, France, 11-12 January 2010 Vaccine 29 2011 1115 1121
37. S.A. Plotkin The Global Pertussis Initiave: process overview Pediatr Infect Dis J 24 5 Suppl 2005 S7 S9
38. Centers for Disease Control, Prevention (CDC) Best practices for health care professionals on the use of polymerase chain reaction (PCR) for diagnosing pertussis. 2011 2011 CDC Atlanta, GA Disponible en: http://www.cdc.gov/ pertussis/clinical/diagnostic-testing/diagnosis-pcr-bestpractices.html
39. P. Lanotte, C. Plouzeau, C. Burucoa, C. Grélaud, S. Guillot, and N. Guiso Evaluation of four commercial real-time PCR assays for detection of Bordetella spp in nasofaryngeal aspirates Clin Microbiol 49 2011 3943 3946
40. B. Abu Raya, E. Bamberger, R. Gershtein, M. Peterman, and I. Srugo The laboratory diagnosis of Bordetella pertussis infection: a comparison of semi-nested PCR and real-time PCR with culture Eur J Clin Micriobiol Infect Dis 31 2012 619 622
41. M.J. Espy, J.R. Uhl, L.M. Sloan, S.P. Buckwalter, M.F. Jones, and E.A. Vetter Real-time PCR in clinical microbiology: applications for routine laboratory testing Clin Microbiol Rev 19 2006 165 256
42. L. Roorda, J. Buitenwerf, J.M. Ossewaarde, and A. van der Zee A real-time PCR assay with improved specificity for detection and discrimination of all clinically relevant Bordetella species by the presence and distribution of three insertion sequence elements BMC Res Notes 4 2011 11
43. K.M. Tatti, K.N. Sparks, K.O. Boney, and M.L. Tondella Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens J Clin Microbiol 49 2011 4059 4066
44. N. Guiso, G. Berbers, N.K. Fry, Q. He, M. Riffelmann, C.H. Wirsing von König EU Pertstrain group What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories Eur J Clin Microbiol Infect Dis 30 2011 307 312
45. R. Srinivasan, and T.H. Yeo Are new macrolides effective in eradicating carriage of pertussis Arch Dis Child 90 2005 322 324
46. Centers for Disease Control and Prevention (CDC) Recommended antimicrobial agents for treatment and postexposure prophylaxis of pertussis: 2005 CDC guidelines MMWR 54 2005 1 16
47. American Academy of Pediatrics Pertussis (whooping cough) L.K. Pickering, C.J. Baker, D.W. Kimberlin, and S.S. Long Red Book: 2012 Report of the Committee on Infectious Diseases 2012 American Academy of Pediatrics Elk Grove Village, IL 553 566
48. National Advisory Committee on Immunization National consensus conference on pertussis. Toronto, Canada, May 25-28, 2002 Can Commun Dis Rep 2953 2003 23
49. H. Dodhia, N.S. Crowcroft, J.C. Bramley, and E. Miller UK guidelines for use of erythromycin chemoprophylaxis in persons exposed to pertussis J Public Health Med 24 2002 200 206
50. J.M. Langley, S.A. Halperin, F.D. Boucher, B. Smith Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis Pediatrics 114 2004 e96 e101
51. M.H. Lebel, and S. Mehra Efficacy and safety of clarithromycin versus erythromycin for the treatment of pertussis: a prospective, randomized, single blind trial Pediatr Infect Dis J 20 2001 1149 1154
52. R.A. Devasia, T.F. Jones, B. Collier, and W. Schaffner Compliance with azithromycin versus erythromycin in the setting of a pertussis outbreak Am J Med Sci 337 2009 176 178
53. Altunaiji S, Kukuruzovic R, Curtis N, Massie J. Antibiotics for whooping cough (pertussis). Cochrane Database Syst Rev. 2007; 3:CD004404. [consultado 26 ene 2013]. Disponible en: http://summaries.cochrane.org/CD004404
54. A.C. Bowen, M.J. Ferson, L.V. Graudins, and P. Palasanthiran Pertussis prevention and treatment: a call for wider access to azithromycin Med J Aust 190 2009 388 389
55. M. Hauben, and G.W. Amsden The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental Drug Saf 25 2002 929 942
56. a ed. 2007 ACINDES Madrid 481 543
57. K.M. Edwards, B.D. Meade, M.D. Decker, G.F. Reed, M.B. Rennels, and M.C. Steinhoff Comparison of 13 acellular pertussis vaccines: overview and serologic response Pediatrics 96 1995 548 557
58. K. Stehr, and J.D. Cherry A comparative efficacy trial in Germany in which infants received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) vaccine or DT vaccine Dev Biol Stand 89 1997 58 62
59. J.D. Cherry, U. Heininger, D.M. Richards, J. Storsaeter, L. Gustafsson, and M. Ljungman Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis Clin Vaccine Immunol 17 2010 741 747
60. L. Zhang, S.O. Prietsch, I. Axelsson, and S.A. Halperin Acellular vaccines for preventing whooping cough in children Cochrane Database Syst Rev 3 2012 CD001478
61. M. Watanabe, and M. Nagai Acellular pertussis vaccines in Japan: past, present and future Expert Rev Vaccines 4 2005 173 184
62. H.O. Hallander, and L. Gustafsson Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience Expert Rev Vaccines 8 2009 1303 1307
63. L. Nilsson, T. Lepp, K. von Segebaden, H. Hallander, and L. Gustafsson Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalization after one and two doses: analysis of 10 years of pertussis surveillance Vaccine 30 2012 3239 3247
64. M.D. Decker, K.M. Edwards, M.C. Steinhoff, M.B. Rennels, M.E. Pichichero, and J.A. Englund Comparison of 13 acellular pertussis vaccines: adverse reactions Pediatrics 96 1995 557 566
65. T. Jefferson, M. Rudin, and C. DiPietrantonj Systematic review of the effects of pertussis vaccines in children Vaccine 21 2003 2003 2014
66. T.L. Johns, and G.E. Hutter New combination vaccines: DTaP-IPV (Kinrix) and DTaP-IPV/Hib (Pentacel) Ann Pharmacother 44 2010 515 523
67. S.A. Plotkin, J. Liese, S.A. Madhi, and E. Ortiz A DTaP-IPV/RPR-T vaccine (Pentaxim): a review of 16 years' clinical experience Expert Rev Vaccines 10 2011 981 1005
68. F. Zepp, H.J. Schmitt, J. Cleerbout, T. Verstraeten, L. Schuerman, and J.M. Jacquet Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine) Expert Rev Vaccines 8 2009 663 678
69. ®. [consultado 26 ene 2013]. Disponible en: http://www.aemps.gob.es/cima/especialidad.do?metodo= verFichaWordPdf&codigo=63993&formato=pdf&formulario=FICHAS&file= ficha.pdf
70. M. Van der Wielen, P. van Damme, E. Joosens, G. François, F. Meurice, and A. Ramalho A randomised controlled trial with a diphteria-tetanus acellular pertussis (dTpa) vaccine in adults Vaccine 18 2000 2075 2082
71. I. Bartels, J. Jungert, S. Lugauer, K. Stehr, and L. Heininger Immunogenicity and reactogenicity of a single dose of a diphteria-tetanus- acellular pertussis component vaccine (DtaP) compared to a diphteria-tetanus toxoid (Td and a diphteria toxoid vaccine (d) in adults Vaccine 19 2000 3137 3145
72. P.F. McIntyre, F.M. Turnbull, A.M. Egan, M.A. Burgess, J.M. Wolter, and L.M. Schuerman High levels of antibody in adults three years after vaccination with a reduced antigen content diphteria-tetanus-acellular pertussis vaccine Vaccine 23 2004 380 385
73. T. Le, J.D. Cherry, S.J. Chang, M.D. Knoll, M.L. Lee, and S. Barenkamp Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study J Infect Dis 190 2004 535 544
74. F. Zepp, M. Knuf, P. Habermehl, W. Mannhardt-Laakmann, B. Howe, and L.R. Friedland Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine J Pediatr 149 2006 603 610
75. N.P. Klein, J. Bartlett, A. Rowhani-Rahbar, B. Fireman, and R. Baxter Waning protection after fifth dose of acellular pertussis vaccine in children N Engl J Med 367 2012 1012 1019
76. J.I. Ward, J.D. Cherry, S.J. Chang, S. Partridge, W. Keitel, and K. Edwards Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized acellular pertussis vaccine trial (APERT) Clin Infect Dis 43 2006 151 157
77. C.U. Meyer, P. Habermehl, M. Knuf, B. Hoet, J. Wolter, and F. Zepp Immunogenicity and reactogenicity of acellular pertusis booster vaccines in children Hum Vaccin 4 2008 203 209
78. J.I. Ward, J.D. Cherry, S.J. Chang, S. Partridge, H. Lee, and J. Treanor Efficacy of an acellular pertussis vaccine among adolescents and adults N Engl J Med 353 2005 1555 1563
79. ®. [consultado 26 ene 2013]. Disponible em: http://www.aemps.gob.es/cima/especialidad.do?metodo= verFichaWordPdf&codigo=71870&formato=pdf&formulario=FICHAS&file= ficha.pdf
80. J.B. Robbins, R. Schneerson, J.M. Keith, M.A. Miller, J. Kubler Kielb, and B. Trollfors Pertussis vaccine: a critique Pediatr Infect Dis J 28 2009 237 241
81. European Centre for Disease Prevention and Control. Pertussis vaccination overview in European countries. [consultado 30 oct 2012]. Disponible en: http://ecdc.europa.eu/en/activities/surveillance/euvac/schedules/Pages/ pertussis-schedule.aspx
82. WHO. Countries in the world with Tdpa vaccine in adolescents. [consultado 30 oct 2012]. Disponible en: http://apps.who.int/immunization-monitoring/en/ globalsummary/ScheduleResult.cfm
83. Impfempfehlungen der Ständigen Impfkommission am Robert Koch-Institut/Stand Juli 2009 Epidem Bull 30 2009 279 298
84. Vaccination schedules and recommendations from the Haut Conseil de la Santé publique in France Bulletin Épidémiologique Hebdomadaire 16-17 2009 146 176
85. Conseil Supérieur de la Santé. Vaccination anticoquelucheuse (fichier 8547). Vaccination de l'adulte. 2009. [consultado 20 oct 2012]. Disponible en: http://www.belgium.be/en/health/
86. J.D. Cherry Epidemic Pertussis in 2012 - The Resurgence of a Vaccine-Preventable Disease NEJM 367 2012 785 787
87. M. Campins-Martí, H.K. Cheng, K. Forsyth, N. Guiso, S. Halperin, and L.M. Huang Recommendations are needed for adolescent and adult pertussis immunization: rationale and strategies for consideration Vaccine 20 2001 641 646
88. K.D. Forsyth, M. Campins-Martí, J. Caro, J.D. Cherry, D. Greenberg, and N. Guiso New pertussis vaccination strategies beyond infancy: recommendations by the Global Pertussis Initiative Clin Infect Dis 39 2004 1802 1809
89. M. Campins, and F.A. Moraga Vacunación frente a la tos ferina en el adolescente y el adulto Enferm Infecc Microbiol Clin 26 Supl 1 2008 12 19
90. K. Kandola, A. Lea, W. White, and M. Santos A comparison of pertussis rates in the Norwest Terrritories: pre- and postacellular pertussis vaccine introduction in children and adolescents Can J Infect Dis Med Microbiol 16 2005 271 274
91. D. Greenberg, M. Doemland, J. Bettinger, D. Scheifele, S. Halperin IMPACT Investigators Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine. Implications for disease prevention in the United States Pediatr Infect Dis J 28 2009 521 528
92. World Health Organization SAGE. Meeting of the Strategic Advisory Group of Experts on immunization, April 2010 - conclusions and recommendations Wkly Epidemiol Rec 85 2010 197 212
93. H.E. Quinn, and P.B. McIntyre The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia Bull World Health Organ 89 2011 666 674
94. D. Moreno-Pérez, F.J. Álvarez García, J. Arístegui Fernández, F. Barrio Corrales, M.J. Cilleruelo Ortega, J.M. Corretger Rauet Comité Asesor de Vacunas de la Asociación Española de Pediatría, España Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2013 An Pediatr (Barc) 78 2013 59.e1 59.e27
95. Vacuna de difteria y tétanos. Vacunación en adultos. Recomendaciones. Ministerio de Sanidad y Política Social. Febrero 2009. [consultado 26 ene 2013]. Disponible en: http://www.msps.es/ciudadanos/ proteccionSalud/vacunaciones/docs/TetanosDifteria-2009.pdf
96. J. Mertsola, O. van der Meeren, Q. He, A. Linko-Parvinen, G. Ramakrishnan, and L. Mannermaa Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults Clin Infect Dis 51 2010 656 662
97. R. Booy, O. van der Meeren, S.P. Ng, F. Celzo, G. Ramakrishnan, and J.M. Jacquet A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults Vaccine 29 2010 45 50
98. I. Bonmarin, I. Poujol, and D. Levy-Bruhl Nosocomial infections and community clusters of pertussis in France, 2000-2005 Euro Surveill 12 2007 E11 E12
99. N.M. Spearing, R.L. Horvath, and J.G. McCormack Pertussis: adults as a source in healthcare settings Med J Australia 177 2002 568 569
100. A. Ward, J. Caro, L. Bassinet, B. Housset, J.A. O'Brien, and N. Guiso Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France Infect Control Hosp Epidemiol 26 2005 288 292
101. A. Calugar, I. Ortega-Sánchez, T. Tiwari, L. Oakes, J. Jahre, and T. Murphy Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers Clin Infect Dis 42 2006 981 988
102. WHO Pertussis vaccines: WHO position paper Wkly Epidemiol Rec 85 2010 385 400
103. A.M. Wendelboe, E. Njamkepo, A. Bourillon, D.D. Floret, J. Gaudelus, and M. Gerber Transmission of Bordetella pertussis to young infants Pediatr Infect Dis J 26 2007 293 299
104. K.M. Bisgard, F.B. Pascual, K.R. Ehresmann, C.A. Miller, C. Cianfrini, and C.E. Jennings Infant pertussis: who was the source Pediatr Infect Dis J 23 2004 985 989
105. S.C. De Greeff, F.R. Mooi, A. Westerhof, J.M. Verbakel, M.F. Peeters, and C.J. Heuvelman Pertussis disease burden in the household: how to protect young infants Clin Infect Dis 50 2010 1339 1345
106. N.S. Crowcroft, R. Booy, T. Harrison, L. Spicer, J. Britto, and Q. Mok Severe and unrecognised: pertussis in UK infants Arch Dis Child 88 2003 802 806
107. S.A. Halperin, E.E. Wang, B. Law, E. Mills, R. Morris, and P. Déry Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT) Clin Infect Dis 28 1999 1238 1243
108. I. Bonmarin, D. Levy-Bruhl, S. Baron, N. Guiso, E. Njamkepo, V. Caro Renacoq participants Pertussis surveillance in French hospitals: results from a 10 year period Euro Surveill 12 2007 34 38
109. L.A. Castagnini, C.M. Healy, M.A. Rench, S.H. Wootton, F.M. Muñoz, and C.J. Baker Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection Clin Infect Dis 54 2012 78 84
110. Centers for Disease Control and Prevention (CDC) Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged < 12 months. Advisory Committee on Immunization Practices (ACIP), 2011 MMWR 60 2011 1424 1426
111. C.M. Healy, M.A. Rench, and C.J. Baker Implementation of cocooning against pertussis in a high-risk population Clin Infect Dis 52 2011 157 162
112. F.A. Moraga-Llop, and M. Campins Martí Tos ferina: ¿conocemos su incidencia real y cómo controlarla? M. Campins Martí, F.A. Moraga Llop, Vacunas 2005 Prous Science Barcelona 9 23
113. K.D. Forsyth, C.H. Wirsing von Konig, T. Tan, J. Caro, and S. Plotkin Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting Vaccine 25 2007 2634 2642
114. World Health Organization Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and cellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged < 12 months - Advisory Committee on Immunization Practices (ACIP) Wkly Epidemiol Rec 60 2011 1424 1427
115. L. Coudeville, A. van Rie, D. Getsios, J.J. Caro, P. Crépey, and V.H. Nguyen Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects PLoS One 4 2009 e6284
116. T.A. Westra, R. de Vries, J.J. Tamminga, C.J. Sauboin, and M.J. Postma Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in The Netherlands Clin Ther 32 2010 1479 1495
117. D.M. Skowronski, N.Z. Janjua, E.P.S. Tsafack, M. Ouakki, L. Hoang, and G. de Serres The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization Clin Infect Dis 54 2012 318 327
118. C.M. Healy, and C.J. Baker Infant pertussis: what to do next Clin Infect Dis 54 2012 328 330
119. N. Wood, P. McIntyre, H. Marshall, and D. Roberton Acellular pertussis vaccine at birth and one month induces antibody responses by two months Pediatr Infect Dis J 29 2010 209 215
120. N. Wood, and C.A. Siegrist Neonatal immunization: where do we stand Curr Opin Infect Dis 24 2011 190 195
121. C. Belloni, A. de Silvestri, C. Tinelli, M.A. Avanzini, M. Marconi, and F. Strano Immunogenicity of a three-component acellular pertussis vaccine administered at birth Pediatrics 111 2003 1042 1045
122. M. Knuf, H.J. Schmitt, J. Wolter, L. Schuerman, J.M. Jacquet, and D. Kieninger Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants J Pediatr 152 2008 655 660
123. N. Halasa, A. O'Shea, J. Shi, B.J. LaFleur, and K.M. Edwards Poor immune responses to a birth dose of diphteria, tetanus and acellular pertussis vaccine J Pediatr 153 2008 327 332
124. M. Knuf, H.J. Schmitt, J.M. Jacquet, A. Collard, D. Kieninger, and C.U. Meyer Booster vaccination after neonatal priming with acellular pertussis vaccine J Pediatr 156 2010 675 678
125. S.A. Gall, and G.A. Poland A maternal immunization program (MIP): developing a schedule and platform for routine immunization during pregnancy Vaccine 29 2011 9411 9413
126. Centers for Disease Control and Prevention (CDC). Pertussis (whooping cough) vaccination. [consultado 26 ene 2013]. Disponible en: http://www.cdc.gov/vaccines/vpd-vac/pertussis/default.htm
127. American College of Obstetricians and Gynecologists Update on immunization and pregnancy: tetanus, diphtheria, and pertussis vaccination. Committee opinion No. 521 Obstet Gynecol 119 2012 690 691
128. The Joint Committee on Vaccination and Immunisation (JCVI). Temporary programme of pertussis (whooping cough) vaccination of pregnant women, September 27th 2012. [consultado 26 ene 2013]. Disponible en: https://www.wp.dh.gov.uk/ publications/files/2012/09/CMO-Pertussis-27-09-2012-FINAL.pdf
129. Y.A. Zheteyeva, P.L. Moro, N.K. Tepper, S.A. Rasmussen, F.E. Barash, and N.V. Revzina Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women Am J Obstet Gynecol 207 2012 e1 e7
130. Garret A. Meeting of the Advisory Committee on Immunization Practices (ACIP). Decision and cost-effectiveness analysis: maternal vaccination and cocooning. Atlanta, Georgia. June 22-23, 2011.